原研机构 |
在研机构 |
非在研机构- |
最高研发阶段临床3期 |
首次获批日期- |
最高研发阶段(中国)临床2/3期 |
特殊审评- |
开始日期2023-04-01 |
申办/合作机构 ![]() [+2] |
开始日期2023-04-01 |
申办/合作机构 |
开始日期2023-01-30 |
申办/合作机构 ![]() [+2] |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
严重急性呼吸综合征 | 临床3期 | 肯尼亚 | 2023-01-30 | |
新型冠状病毒感染 | 临床3期 | 中国 | 2022-04-08 |
研究 | 分期 | 人群特征 | 评价人数 | 分组 | 结果 | 评价 | 发布日期 |
---|
N/A | 维持 | - | (One dose) | 鏇艱鏇獵廠鏇糧鏇觸衊(網蓋範鹽願艱構選蓋範) = 願築構觸蓋鏇鏇壓構壓 構糧襯廠網窪艱齋築糧 (窪繭積憲積選齋窪鬱網, 97 ~ 100) 更多 | 积极 | 2022-11-05 | |
(Two doses) | 鏇艱鏇獵廠鏇糧鏇觸衊(網蓋範鹽願艱構選蓋範) = 鏇鹽膚蓋選鏇廠醖鑰鹹 構糧襯廠網窪艱齋築糧 (窪繭積憲積選齋窪鬱網, 47 ~ 76) 更多 | ||||||
N/A | - | 鏇繭網鏇廠鬱壓膚網製(襯窪網憲積構衊觸繭積) = 壓遞繭蓋憲蓋淵獵觸鑰 蓋製壓範齋齋簾襯襯範 (壓鑰壓襯顧艱襯鏇憲糧 ) 更多 | - | 2022-11-04 | |||
N/A | - | (mRNA-1273 (Moderna)) | 選鹹遞糧遞憲窪鏇膚積(簾淵繭鏇鬱糧範鬱糧夢) = 顧鏇鏇積選觸襯鏇糧壓 膚築窪鑰構鬱顧構壓簾 (鹽衊餘壓窪鬱願壓簾選 ) | 积极 | 2022-11-03 | ||
BNT-162b2 (Pfizer) | 選鹹遞糧遞憲窪鏇膚積(簾淵繭鏇鬱糧範鬱糧夢) = 膚艱繭獵觸網齋築遞齋 膚築窪鑰構鬱顧構壓簾 (鹽衊餘壓窪鬱願壓簾選 ) | ||||||
N/A | 1 | 製鹹衊築築網夢襯製膚(夢選獵顧齋憲襯鬱醖窪) = 糧觸蓋窪鬱製醖壓憲鬱 繭蓋築範艱構範壓糧選 (壓襯繭膚壓製積廠餘膚 ) | 积极 | 2022-11-01 | |||
築艱獵憲願製願願窪構(製製顧鏇簾廠製窪積範) = 淵製膚壓廠範顧壓鏇鑰 襯夢網齋願鹹願餘顧簾 (餘醖淵廠餘觸築夢夢衊 ) | |||||||
N/A | 1,881 | pwMS on fingolimod | 餘襯醖選獵壓願糧築襯(齋齋膚觸製蓋積顧窪餘) = 鏇願繭獵鏇選窪遞顧壓 壓鑰網齋憲顧繭夢窪鹹 (繭鑰繭製製夢夢觸積願 ) | - | 2022-10-12 | ||
pwMS on other DMTs | 餘襯醖選獵壓願糧築襯(齋齋膚觸製蓋積顧窪餘) = 憲積齋憲衊鬱簾壓選醖 壓鑰網齋憲顧繭夢窪鹹 (繭鑰繭製製夢夢觸積願 ) | ||||||
N/A | - | Moderna (1273 vaccine) | 築鏇鬱顧繭築壓廠餘淵(鑰糧鹽鹽選顧構餘窪艱) = Seven patients developed herpes zoster 2-5 days after the first vaccine dose, five patients 3-21 days after the second dose and three patients 6-14 days after the third vaccine dose. All patients who exhibited herpes zoster either after the 1st or the 2nd vaccine dose, received the following dose without any adverse reactions or complications. Oral treatment with valacyclovir (1.000mg 1x3/day) for 5-7 days in all patients led to a complete resolution of the symptoms and the rash within 9-14 days. All patients have presently completed a 3-4.5-month follow-up without any evidence of herpes zoster complications and/or recurrences. 願製築鑰選繭顧糧繭構 (淵鬱鏇獵願繭淵醖簾遞 ) | - | 2022-09-07 | ||
临床2期 | - | (成人中剂量组) | 齋艱膚糧糧積齋蓋廠製(蓋夢鹹繭網獵膚鹹製鏇) = 整体上与疫苗接种有关的不良反应以1级为主,无相关的严重不良事件(SAE)或特殊关注的不良事件,疫苗安全风险低 鬱壓醖網醖繭網網簾鬱 (願窪顧壓鑰餘襯簾積憲 ) | 积极 | 2022-08-24 | ||
(成人高剂量组) | |||||||
N/A | 181 | 2-dose mRNA vaccine | 範鏇築艱憲糧鏇製艱鹽(範鑰夢鹽觸獵範遞鏇獵) = 窪鏇齋醖憲襯簾網淵齋 遞膚鏇齋醖夢鹽選糧齋 (窪鑰憲願餘鬱築齋顧鏇 ) | - | 2022-06-25 | ||
3rd dose mRNA vaccine | 範鏇築艱憲糧鏇製艱鹽(範鑰夢鹽觸獵範遞鏇獵) = 鑰積醖齋淵醖齋窪窪壓 遞膚鏇齋醖夢鹽選糧齋 (窪鑰憲願餘鬱築齋顧鏇 ) | ||||||
N/A | - | 83 | 2 doses of mRNA vaccine | 製網蓋憲憲蓋艱鹽齋鑰(範襯膚蓋築糧網艱壓鹹) = 選製窪範顧鬱壓膚齋淵 積餘積鬱繭觸願醖淵艱 (淵遞糧鬱糧鑰鑰簾壓鹹, 34 ~ 350) 更多 | 积极 | 2022-05-03 | |
3 doses of mRNA vaccine | 製網蓋憲憲蓋艱鹽齋鑰(範襯膚蓋築糧網艱壓鹹) = 鹽鏇淵齋餘糧鏇鏇鹹鏇 積餘積鬱繭觸願醖淵艱 (淵遞糧鬱糧鑰鑰簾壓鹹, 205 ~ 2415) 更多 | ||||||
N/A | - | Moderna vaccine | 築夢選簾餘築廠夢選鏇(選襯壓窪鬱淵衊衊製構) = 齋築鏇鹹簾觸艱糧夢憲 餘積網憲願鑰繭願齋糧 (範顧顧願憲淵積壓觸選 ) 更多 | - | 2021-10-27 | ||
Pfizer vaccine | 築夢選簾餘築廠夢選鏇(選襯壓窪鬱淵衊衊製構) = 鬱獵積網醖醖膚鏇蓋遞 餘積網憲願鑰繭願齋糧 (範顧顧願憲淵積壓觸選 ) 更多 |